Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

157.99 +2.55 (+1.64%)
Streaming Delayed Price Updated: 11:20 AM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
2 Reasons to Like IRTC (and 1 Not So Much)
Over the past six months, iRhythm has been a great trade, beating the S&P 500 by 27.6%. Its stock price has climbed to $187.29, representing a healthy 39.1% increase. This was partly due to its solid... 
Via StockStory
Topics Stocks Supply Chain
News headline image
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
Why iRhythm (IRTC) Stock Is Up Today
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.4% in the afternoon session after Morgan Stanley raised its price target on the stock from $195 to $205. 
Via StockStory
News headline image
1 Mooning Stock with Promising Prospects and 2 Facing Challenges
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions. 
Via StockStory
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About iRhythm Technologies? ↗
 
Via Benzinga
News headline image
1 Russell 2000 Stock with Solid Fundamentals and 2 We Question
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after a report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. 
Via StockStory
Topics Economy
News headline image
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
How Do Investors Really Feel About iRhythm Technologies Inc? ↗
 
Via Benzinga
News headline image
5 Must-Read Analyst Questions From iRhythm’s Q3 Earnings Call
iRhythm’s third quarter results were driven by strong commercial momentum across both core Zio Monitor and Zio AT products, with management citing a record number of new account openings and expanded... 
Via StockStory
Topics Earnings
News headline image
IRHYTHM TECHNOLOGIES INC (NASDAQ:IRTC) Shows Strong Growth Momentum and Technical Health ↗
IRTC stock shows strong uptrend with accelerating sales and earnings growth, fitting the High Growth Momentum + Trend Template for potential continued gains. 
Via Chartmill
News headline image
iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook ↗
iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gained analyst confidence with higher price targets. 
Via Benzinga
News headline image
Why iRhythm (IRTC) Stock Is Trading Up Today
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session after it reported strong third-quarter financial results that surpassed expectations and... 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
IRTC Q3 Deep Dive: New Account Growth and AI Partnerships Fuel Guidance Raise
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 30.7% year on year to $192.9 million. The company’s... 
Via StockStory
Topics Artificial Intelligence
News headline image
iRhythm Technologies Inc (NASDAQ:IRTC) Surpasses Q3 Expectations and Raises 2025 Outlook ↗
iRhythm stock surges after Q3 earnings crush estimates. Revenue jumps 30.7% and the company narrows its loss, raising its full-year outlook. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
iRhythm (NASDAQ:IRTC) Beats Expectations in Strong Q3, Stock Soars
Medical technology company iRhythm Technologies (NASDAQ:IRTC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 30.7% year on year to $192.9 million. The company’s full-year revenue... 
Via StockStory
News headline image
iRhythm Earnings: What To Look For From IRTC
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results this Thursday after market close. Here’s what you need to know. 
Via StockStory
News headline image
3 Unprofitable Stocks We Find Risky
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
Forecasting The Future: 14 Analyst Projections For iRhythm Technologies ↗
 
Via Benzinga
News headline image
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
What's Driving the Market Sentiment Around iRhythm Technologies Inc? ↗
 
Via Benzinga
News headline image
Q2 Earnings Recap: iRhythm (NASDAQ:IRTC) Tops Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Healthcare Stocks to Research Further and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
News headline image
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics Government World Trade
News headline image
IRHYTHM TECHNOLOGIES INC (NASDAQ:IRTC) Combines Technical Strength and Growth Momentum ↗
IRTC stock combines strong technical trends with accelerating fundamentals, aligning with Mark Minervini's high-growth strategy for potential continued gains. 
Via Chartmill
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 We Question
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
Expert Outlook: iRhythm Technologies Through The Eyes Of 9 Analysts ↗
 
Via Benzinga
News headline image
1 Growth Stock to Add to Your Roster and 2 We Brush Off
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.